 |
Medytox.(photo=medytox) |
[Alpha Biz= Reporter Kim Jisun] Medytox saw a strong surge in its stock price as it opened up a new avenue for selling its new hyaluronic acid filler products in Indonesia.
According to the Korea Exchange on the 23rd, Medytox closed at 136,900 won, up 6.37% (8,200 won) from the previous day. At one point, it traded as high as 141,100 won on the KOSDAQ market, briefly reaching a market capitalization of around 1 trillion won.
Earlier, on the 20th, Medytox announced it had obtained regulatory approval in Indonesia for three types of hyaluronic acid (HA) fillers. These fillers inject hyaluronic acid, a biocompatible substance that softens joints or skin, under the skin to improve wrinkles.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
